Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Payoneer Global Inc (PAYO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Payoneer Global Inc — how do they compare? Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B), while Payoneer Global Inc trades at $7.13 (market cap $2.42B). The key difference: Hinge Health Inc. Class A Common Stock is far larger — about 3.5× Payoneer Global Inc's market cap, and Hinge Health Inc. Class A Common Stock is more actively traded (879,799 versus 1,032,721). Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Payoneer Global Inc for 62 Days on average.
| HNGE | PAYO | |
|---|---|---|
Market Cap | $8.48B | $2.42B |
Volume | 879,799 | 1,032,721 |
Sector | Health | Technology |
52-Week High | $105.14 | $7.18 |
52-Week Low | $31.17 | $4.27 |
Typical Hold Time | 0 Days | 62 Days |
Enterprise Value | $8.10B | $2.16B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Payoneer Global (PAYO) trades at $7.14, up 0.28% on the day, with a mixed technical outlook showing a bullish overall signal but bearish moving averages. Fundamentally, the company reported Q2 2026 earnings of $0.02 per share, missing estimates, but revenue grew 10% excluding interest. Recent news highlights the renewal of its partnership with Etsy through 2029 and an agreement to be acquired by Nuvei, announced on June 15, 2026.
The outlook is shaped by the pending acquisition, which offers a potential exit for shareholders, but execution risks and recent earnings misses pose concerns. Analyst sentiment is positive with a 60% buy rating, yet investors should weigh acquisition certainty against operational performance volatility and competitive pressures in the fintech sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Payoneer Global Inc
Payoneer Global Inc is the world's go-to partner for digital commerce, everywhere. The company started as a cross-border payments platform that empowers businesses, online sellers, and freelancers. The platform allows the users to get paid in multiple currencies, bill global clients, and sell on marketplaces worldwide.
Read more on PAYO →
